BBOT

BridgeBio Oncology
BBOT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$26
178% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Robert Burns
0% 1-yr BBOT win rate
6 Mar ‘26 1 month ago
Stifel
Stifel
Laura Prendergast
0% 1-yr BBOT win rate
11 Feb ‘26 2 months ago